carbapenems has been researched along with Burns in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (4.76) | 18.2507 |
2000's | 1 (2.38) | 29.6817 |
2010's | 30 (71.43) | 24.3611 |
2020's | 9 (21.43) | 2.80 |
Authors | Studies |
---|---|
Botha, A; Brink, AJ; Copelyn, J; Eley, B; Tootla, HD | 1 |
Arif, F; Hill, DM; Martin, K; Sultan-Ali, I; Velamuri, SR | 1 |
Cleland, H; Padiglione, A; Stewardson, AJ; Tracy, LM | 1 |
Beiwen, W; Erzhen, C; Qin, Z; Yi, D; Yin, Z; Zhenzhu, M | 1 |
Abbassi, MS; Achour, W; Chebbi, Y; Frigui, S; Hmissi, S; Raddaoui, A; Thabet, L | 1 |
Cotta, MO; Dulhunty, JM; Eriksson, L; Harris, P; Malacova, E; Milinovich, GJ; Vickers, ML | 1 |
Donat, N; Leclerc, T; Ragot, C; Schaal, JV; Soler, C | 1 |
Choi, YK; Jeon, J; Lee, J; Park, JJ; Seo, YB | 1 |
Al-Delaimi, MS; Yacoob Aldosky, HY | 1 |
Adibkia, K; Farajnia, S; Ghotaslou, R; Kafil, HS; Khalili, Y; Memar, MY | 1 |
Emaneini, M; Jabalameli, F; Kalantar-Neyestanaki, D; Mirsalehian, A; Taherikalani, M | 1 |
Cheng, MH; Chuang, SS; Hsieh, YC; Huang, CT; Huang, PY; Lin, SP; Liu, TP; Shie, SS; Wu, TL; Wu, TS; Ye, JJ | 1 |
Farahani, A; Farajzadeh Sheikh, A; Jolodar, A; Rostami, S; Sheikhi, R; Shoja, S; Tabatabaiefar, MA | 1 |
Huan, JN; Xiang, J | 1 |
Ardebili, A; Ghaemi, EA; Hashemi, A; Javid, N; Najari, E; Yazdansetad, S | 1 |
Aghazadeh, M; Hojabri, Z; Mahdian, R; Nahaei, MR; Pajand, O; Rezaee, MA; Soroush, MH; Tabrizi, MS | 1 |
AI-Awad, O | 1 |
Batailler, P; Cheong Sing, JS; Ducki, S; Forli, A; Maillet, M; Mallaret, MR; Marfaing, S; Pelloux, I; Vancoetsem, K | 1 |
Emaneini, M; Jabalameli, F; Mirsalehian, A; Neyestanaki, DK; Rezagholizadeh, F; Taherikalani, M | 1 |
Mahdian, R; Nahaei, MR; Pajand, O | 1 |
Banerjee, P; Singh, G | 1 |
Asadollahi, K; Emaneini, M; Jabalameli, F; Kalantar-Neyestanaki, D; Taherikalani, M | 1 |
Eftekhar, F; Salimi, F | 1 |
Decosterd, LA; Eggimann, P; Fournier, A; Marchetti, O; Pagani, JL; Pannatier, A; Que, YA; Revelly, JP; Voirol, P | 1 |
Azimi, L; Lari, AR; Soroush, S; Taherikalani, M | 1 |
Huan, J | 1 |
Dinghong, M; Fei, G; Guanghua, G; Guohui, L; Jianhua, Z; Nianyun, W; Xili, Y; Yue, L | 1 |
Fransén, J; Hanberger, H; Huss, FR; Nilsson, LE; Rydell, U; Sjöberg, F | 1 |
Calomino, MA; de Almeida Silva, KCF; de Castilho, SR; de Paula, GR; Deutsch, G; Esper, LMR; Teixeira, LA | 1 |
Lin, YT | 1 |
Ahmadi, K; Ebrahimifard, N; Farahani, A; Moosavian, M; Peymani, A; Rostami, S; Shoja, S | 1 |
Bian, J; Ning, FG; Zhang, GA; Zhao, XZ | 1 |
Clifford, RJ; Hang, J; Kuschner, RA; Kwak, YI; Lesho, EP; McGann, P; Waterman, PE; Yang, Y | 1 |
Alaghehbandan, R; Azimi, L; Fallah, F; Rahbar, M; Rastegar Lari, A | 1 |
Liu, J; Liu, XL; Peng, DZ; Shu, WT; Xue, L; Zhou, X | 1 |
Asghari, B; Azimi, L; Gholami, A; Lari, AR; Owlia, P | 1 |
Aypak, C; Bayram, I; Bayram, Y; Parlak, M | 1 |
Emaneini, M; Jabalameli, F; Kalantar, D | 1 |
Alaghehbandan, R; Lari, AR | 1 |
Akcay, MN; Aktas, F; Altoparlak, U; Celebi, D; Ozkurt, Z | 1 |
Domon, H; Fukuoka, T; Hirasawa, A; Ishii, C; Kakuta, M; Ohya, S; Utsui, Y; Yasuda, H | 1 |
Johnson, AP; Kaufmann, ME; Livermore, DM; Weinbren, MJ | 1 |
1 review(s) available for carbapenems and Burns
Article | Year |
---|---|
Modifiable risk factors for multidrug-resistant Gram-negative infection in critically ill burn patients: a systematic review and meta-analysis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Burns; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Drug Resistance, Multiple; Gram-Negative Bacterial Infections; Humans; Hydrotherapy; Intensive Care Units; Penicillins; Respiration, Artificial; Risk Factors; Urinary Catheters; Vascular Access Devices | 2019 |
41 other study(ies) available for carbapenems and Burns
Article | Year |
---|---|
Using ceftazidime-avibactam for persistent carbapenem-resistant Serratia marcescens infection highlights antimicrobial stewardship challenges with new beta-lactam-inhibitor combination antibiotics.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Azabicyclo Compounds; Burns; Carbapenems; Ceftazidime; Drug Combinations; Female; Humans; Infant; Serratia Infections; Serratia marcescens; South Africa | 2021 |
Analysis of Ceftazidime/Avibactam Use for Treating Carbapenem-Resistant Infections in Critically Ill Patients With Thermal or Inhalation Injuries.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Burns; Carbapenems; Ceftazidime; Critical Illness; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests | 2022 |
Patterns of multidrug resistant organism acquisition in an adult specialist burns service: a retrospective review.
Topics: Adult; Anti-Bacterial Agents; Burns; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Retrospective Studies; Vancomycin-Resistant Enterococci | 2022 |
Characteristics of bloodstream infection and initial antibiotic use in critically ill burn patients and their impact on patient prognosis.
Topics: Anti-Bacterial Agents; Burns; Carbapenems; China; Critical Illness; Humans; Klebsiella pneumoniae; Lincomycin; Prognosis; Retrospective Studies; Sepsis | 2022 |
Detection of carbapenem resistant Pseudomonas aeruginosa co-harboring blaVIM-2 and blaGES-5 in burn patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies | 2023 |
Carbapenem-resistant Acinetobacter baumannii in Military Burn Centre.
Topics: Acinetobacter baumannii; Burn Units; Burns; Carbapenems; Humans; Military Personnel | 2020 |
Colistin monotherapy versus colistin-based combination therapy for treatment of bacteremia in burn patients due to carbapenem-resistant gram negative bacteria.
Topics: Adult; Aged; Bacteremia; Burns; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Republic of Korea; Retrospective Studies | 2020 |
Amending the Efficiency of Antimicrobials against Multidrug-Resistant Pseudomonas aeruginosa by Low-Frequency Magnetic Fields.
Topics: Aminoglycosides; Anti-Bacterial Agents; Burns; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Magnetic Fields; Microbial Sensitivity Tests; Penicillins; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones | 2020 |
Molecular epidemiology and carbapenem resistance of
Topics: Anti-Bacterial Agents; beta-Lactamases; Burns; Carbapenems; Humans; Iran; Microbial Sensitivity Tests; Molecular Epidemiology; Pseudomonas aeruginosa; Pseudomonas Infections; Random Amplified Polymorphic DNA Technique | 2021 |
Determination of carbapenem resistance mechanism in clinical isolates of Pseudomonas aeruginosa isolated from burn patients, in Tehran, Iran.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Drug Resistance, Microbial; Humans; Iran; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Wound Infection | 2017 |
Acquisition and clearance of multidrug resistant Acinetobacter baumannii on healthy young adults concurrently burned in a dust explosion in Taiwan: the implication for antimicrobial stewardship.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; Burns; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Dust; Explosions; Female; Humans; Intensive Care Units; Male; Retrospective Studies; Taiwan; Young Adult | 2017 |
Investigating of four main carbapenem-resistance mechanisms in high-level carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
Topics: Anti-Bacterial Agents; Burns; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2018 |
[Further understanding of infection of carbapenems-resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Carbapenem-resistant Acinetobacter baumannii isolates carrying bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Female; Humans; Iran; Male; Microbial Sensitivity Tests; Sequence Analysis, DNA | 2019 |
Study of the carbapenem resistance mechanisms in clinical isolates of Acinetobacter baumannii: comparison of burn and non-burn strains.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2013 |
Acinetobacter baumannii using several mechanisms for carbapenem resistance.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Burns; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans | 2014 |
Nosocomial transmission of carbapenem-resistant Pseudomonas aeruginosa among burn patients.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; Burns; Carbapenems; Cross Infection; Disk Diffusion Antimicrobial Tests; Female; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Tunisia | 2014 |
Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burns; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Random Amplified Polymorphic DNA Technique | 2014 |
Response to letter to the editor: Acinetobacter baumannii using several mechanisms for carbapenem resistance.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Burns; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans | 2014 |
Molecular methods require for confirmation in bla AIM (Adelaide imipenemase) producing Pseudomonas aeruginosa.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burns; Carbapenems; Cross Infection; Genes, Bacterial; Humans; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Reply to: Molecular methods require for confirmation blaAIM (Adelaide imipenemase) producing Pseudomonas aeruginosa.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burns; Carbapenems; Cross Infection; Genes, Bacterial; Humans; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Prevalence of blaIMP, and blaVIM gene carriage in metallo-β-lactamase-producing burn isolates of Pseudomonas aeruginosa in Tehran.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Drug Resistance, Microbial; Humans; Iran; Microbial Sensitivity Tests; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Body Surface Area; Burn Units; Burns; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Computer Systems; Critical Illness; Drug Combinations; Drug Monitoring; Female; Humans; Imipenem; Length of Stay; Male; Meropenem; Middle Aged; Retrospective Studies; Thienamycins; Young Adult | 2015 |
Low prevalence of metallo-beta-lactamase in Pseudomonas aeruginosa isolated from a tertiary burn care center in Tehran.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Cross Infection; Humans; Iran; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Tertiary Care Centers | 2015 |
[Controlling infection and spread of carbapenems-resistant Klebsiella pneumoniae among burn patients].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burns; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2015 |
[Analysis of the mechanism of drug resistance of VIM-2-type metallo-β-lactamase-producing Acineto- bacter baumannii isolated from burn patients and its homology].
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Sulbactam | 2015 |
Surveillance of antibiotic susceptibility in a Swedish Burn Center 1994-2012.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Burn Units; Burns; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella; Klebsiella Infections; Linear Models; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Sweden; Urinary Tract Infections; Wound Infection; Young Adult | 2016 |
Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Biofilms; Brazil; Burn Units; Burns; Carbapenems; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
What can we learn from the dissemination of carbapenem-resistant Acinetobacter baumannii in patients with burn injury?
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Burns; Carbapenems; Humans | 2017 |
Dissemination of carbapenem-resistant Acinetobacter baumannii in patients with burn injuries.
Topics: Acinetobacter baumannii; Burns; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests | 2017 |
Large-area burns with pandrug-resistant Pseudomonas aeruginosa infection and respiratory failure.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Burns; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Humans; Macrolides; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Insufficiency; Retrospective Studies; Young Adult | 2011 |
Complete sequence of a novel 178-kilobase plasmid carrying bla(NDM-1) in a Providencia stuartii strain isolated in Afghanistan.
Topics: Afghanistan; beta-Lactamases; Burns; Carbapenems; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Providencia; Quinolones; Real-Time Polymerase Chain Reaction | 2012 |
Phenotypic detection of Klebsiella pneumoniae carbapenemase among burns patients: first report from Iran.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Iran; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Young Adult | 2013 |
[Analysis of resistance phenotype and homology of Klebsiella pneumoniae in burn patients].
Topics: Anti-Bacterial Agents; Burns; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sequence Homology | 2012 |
ESBL- and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Burn Units; Burns; Carbapenems; Ceftazidime; Child; Child, Preschool; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Infant; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Prevalence; Young Adult | 2012 |
Three-year review of bacteriological profile and antibiogram of burn wound isolates in Van, Turkey.
Topics: Adult; Amikacin; Burns; Carbapenems; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infections; Male; Retrospective Studies; Turkey | 2013 |
The modified Hodge test for identification of Klebsiella pneumoniae carbapenemase producing isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella; Klebsiella Infections; Male | 2013 |
Response to letter to the editor: 'The modified Hodge test for identification of Klebsiella pneumoniae carbapenemase producing isolates'.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella; Klebsiella Infections; Male | 2013 |
Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Burn Units; Burns; Carbapenems; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Opportunistic Infections; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
[Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Burns; Carbapenems; Carrier Proteins; Drug Resistance, Microbial; Drug Synergism; Hexosyltransferases; Methicillin Resistance; Mice; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin | 1997 |
Acinetobacter spp. isolates with reduced susceptibilities to carbapenems in a UK burns unit.
Topics: Acinetobacter; beta-Lactam Resistance; beta-Lactamases; Burns; Carbapenems; DNA, Bacterial; Humans; Intensive Care Units; United Kingdom | 1998 |